Literature DB >> 32475608

Novel coronavirus (2019-nCov): do you have enough intensive care units?

G Melegari1, E Giuliani2, G Maini2, L Barbieri2, P Baffoni3, E Bertellini3, A Barbieri4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32475608      PMCID: PMC7158803          DOI: 10.1016/j.medin.2020.04.007

Source DB:  PubMed          Journal:  Med Intensiva (Engl Ed)        ISSN: 2173-5727


× No keyword cloud information.
Recently, the World Health Organization declared the novel coronavirus (2019-nCov) a global health emergency due to its global implications for the health care system and its economic impact. Italy was one of the first European countries with registered clustered cases of acute pneumonia. On February 23, 2020, the Italian government declared the first set of quarantine measures to slow the spread of the virus. Estimations show that 2019-nCoV is a high-diffusion virus with a 2% fatality rate; approximately 20% all hospital admissions were directly to the ICU. National health care systems could collapse if this spread of pneumonia continues at the current rate. This study aims to analyze official Italian data to build a predictive model. From February 23, 2020 to March 15, 2020, daily data from the cumulative reports of the Protezione Civile Italiana (Italian Civil Protection) were collected, including the number of positive subjects, hospital admissions, ICU admissions, deaths, and full recovery. Statistical programs were used for the analysis. Different models were tested, and forecast values were calculated, and the best model, with a p-value <0.05, was considered to calculate the predicted values. The number of positive subjects (PS) follows a non-linear regression with p  < 0.001 for the number of PS and hospital admissions, PS and ICU admissions, PS and deaths, and PS and recovered subjects. Simultaneously, the number of people admitted to hospitals follows a non-linear regression with p  < 0.001 (Table 1 ). Among the 46.7% of PS admitted in hospitals, 10.0% were admitted to the ICU. The ratio of hospitalized patients to those admitted to the ICU is 22.3%, the death rate is 5%, and the recovery rate is 8%. The relationship between hospital admissions and ICU admissions follows a linear regression, with p  < 0.001. Recent data on 2019-n CoV present different non-linear growth patterns, besides the rapidly increasing number of PS, which are very susceptible to public health rules. It is fascinating to observe the constant ratio of hospitalized and ICU admissions. If, in the next few weeks, infections reach 1% of the Italian population, over 60.000 ICU beds will be required, which may be the breaking point for the system. These results could be confirmed and highlighted by the increasing trend of ICU admissions, and the relationship between hospitalized patients and ICU admitted subjects. The national health care system needs more time to adapt to and deal with this challenge. The 2019 n-CoV transmission probability presents the following relationship. . Here, indicates infected subjects, x is the intrinsic potential reproducing number, and the constants and are the intercepts. With environmental strategies and adequate medical treatments, infection and death rates reduced, while recovery rates increased (Fig. 1 a and b). Observing Italy's data, this equation is applicable to hospital and ICU admission, and to the rate of death and recovery. As in China, quarantine and environmental strategies have a positive, but slow effect. They can reduce the rate of infection, admissions to ICU, and death, and can change the model. Furthermore, this is a preliminary interpretation, and not the end of this phenomenon. It will be possible to analyze, customize, and fit the best model. However, in this context, it is important not to forget the emergency; necessary medical and surgical procedures should be guaranteed. A possible solution is to try to re-organize the mission of the hospital as happened in different and less dramatic events. This model has the potential to predict the worst-case scenario. With this knowledge, we are ready to do the best to prevent the system from reaching the breaking point and to change the 2019 nCoV curve now!
Table 1

Data from February 23 until March 15, 2020. Left panel: number of 2019-nCov positive subjects, number of hospital admissions and ICU admissions, number of deaths, and recovery. Right panel: predicted mean value calculated using non- linear regression. R2 describes the goodness of fit, where 1 indicates a complete fit.

DayNumber of patients
Predicted number
2019-nCov positiveHospital admissionICU AdmissionDeathRecovery2019-nCov positiveHospital admissionICU AdmissionDeathRecovery
1132542650395128017
22291012761224892780
3322114351013861253112−7
4400128361235411693915−4
565024856124570522852179
6888345642146892312722032
7104940110529501118427992564
816946391403483139958313335106
9183574216652149175078717750159
1022631034229791602187104822973220
112706134629510727627251374292104292
123296179035114841433801774366145373
133916239446219752341682255452198464
145061265156723358951032826550264564
156378355765036662262023496662345674
16798543167334637337.4954.151757474773
178514503887763110049.0264.878881627940
1810590583810288271045107895.67510178111134
19128396650115310161258128026.543116510311357
20149957246132812661439150847.484132612881610
21177508372151814411966176538.500149815861897
22206039663167220632335205289.593168419292218



R20.9990.9980.9990.9930.988
p0.0010.0010.0010.0010.001
Figure 1

(a) Reports the model curve and its fitting curve of positive subjects of 2019-nCov, hospital and ICU admissions, death, and recovery. (b) Reports the ICU admission trend with a moving averages relation.

Data from February 23 until March 15, 2020. Left panel: number of 2019-nCov positive subjects, number of hospital admissions and ICU admissions, number of deaths, and recovery. Right panel: predicted mean value calculated using non- linear regression. R2 describes the goodness of fit, where 1 indicates a complete fit. (a) Reports the model curve and its fitting curve of positive subjects of 2019-nCov, hospital and ICU admissions, death, and recovery. (b) Reports the ICU admission trend with a moving averages relation.

Funding

None declared. The Study follows Strobe Guidelines. Database: data are available on http://www.protezionecivile.gov.it/attivita-rischi/rischio-sanitario/emergenze/coronavirus. Statistic calculate were performed using Microsoft Excel® and STATA 16® program (STATA Corp LP 4905 Lakeway Drive TX 77845 USA by a physician (with statistic competence) and by an engineer: all calculate were attached as supplementary file.

Author contributions

Melegari G and Barbieri A: concept design of the study, statistic calculate, Maini G: statistic calculate and control, Giuliani E: writing of the paper, Barbieri L: graphical aspects, Baffoni P and Bertellini E: manuscript revision and final approval.

Keypoints

The study analyzes the Italian Novel Coronavirus (2019-nCov) outbreaks, searching possible predicting model, underlining the risk of the trend of phenomena.

Conflict of interest

None.
  5 in total

1.  The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy.

Authors:  Stefano Spina; Francesco Marrazzo; Maurizio Migliari; Riccardo Stucchi; Alessandra Sforza; Roberto Fumagalli
Journal:  Lancet       Date:  2020-02-28       Impact factor: 79.321

2.  Response by Twin Italian Hub Hospitals in a Double Seismic Event: A Retrospective Observational Investigation.

Authors:  Alberto Barbieri; Gabriele Melegari; Valentina Lob; Lorenzo Mazzali; Luca D'Amelio; Andrea Giovannoni; Enrico Giuliani
Journal:  Prehosp Emerg Care       Date:  2018-01-18       Impact factor: 3.077

3.  Fitting dynamic models to epidemic outbreaks with quantified uncertainty: A Primer for parameter uncertainty, identifiability, and forecasts.

Authors:  Gerardo Chowell
Journal:  Infect Dis Model       Date:  2017-08-12

4.  Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020.

Authors:  K Roosa; Y Lee; R Luo; A Kirpich; R Rothenberg; J M Hyman; P Yan; G Chowell
Journal:  Infect Dis Model       Date:  2020-02-14

Review 5.  Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients.

Authors:  Randy S Wax; Michael D Christian
Journal:  Can J Anaesth       Date:  2020-02-12       Impact factor: 6.713

  5 in total
  4 in total

1.  Permissive apnea in CoVid 19 Tracheostomy: alternative healthworkers safe procedure in Intensive Care Unit.

Authors:  Andrea Marudi; Giacomo Branchetti; Elisabetta Bertellini
Journal:  Ann Thorac Surg       Date:  2020-07-09       Impact factor: 4.330

2.  Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up.

Authors:  Lorenzo Gamberini; Carlo Alberto Mazzoli; Harri Sintonen; Davide Colombo; Gaetano Scaramuzzo; Davide Allegri; Tommaso Tonetti; Gianluca Zani; Chiara Capozzi; Emanuela Giampalma; Vanni Agnoletti; Filippo Becherucci; Elisabetta Bertellini; Andrea Castelli; Iacopo Cappellini; Irene Cavalli; Federico Crimaldi; Federica Damiani; Maurizio Fusari; Giovanni Gordini; Cristiana Laici; Maria Concetta Lanza; Mirco Leo; Andrea Marudi; Giuseppe Nardi; Irene Ottaviani; Raffaella Papa; Antonella Potalivo; Vito Marco Ranieri; Emanuele Russo; Stefania Taddei; Carlo Alberto Volta; Savino Spadaro
Journal:  Qual Life Res       Date:  2021-05-12       Impact factor: 4.147

3.  Mild to Severe Neurological Manifestations of COVID-19: Cases Reports.

Authors:  Gabriele Melegari; Veronica Rivi; Gabriele Zelent; Vincenzo Nasillo; Elena De Santis; Alessandra Melegari; Claudia Bevilacqua; Michele Zoli; Stefano Meletti; Alberto Barbieri
Journal:  Int J Environ Res Public Health       Date:  2021-04-01       Impact factor: 3.390

4.  Description, Organization, and Individual Postgraduate Perspectives of One Italian School of Anesthesia and Intensive Care.

Authors:  Matteo Villani; Valentina Lob; Anna Del Prete; Emmanuele Guerra; Elisabetta Chili; Elisabetta Bertellini
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.